Date: May 12 through May 14, 2020
Location: South San Francisco, California
Registration: This meeting is open to BIO member company staff engaged in the conduct and reporting of preclinical safety evaluation for biopharmaceuticals. Registration is not limited to BioSafe members, but your company must be a member of BIO. Additional registration information, including rates is forthcoming.